Stock listing
WF60 Stock Price, News, Filings & Events — Mindbio Therapeutics Corp.
Selected listing: WF60 · GETTEX · EUR · DE
This page tracks Mindbio Therapeutics Corp.'s WF60:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following WF60:GETTEX. WF60:GETTEX is the stock-level entry point for investors researching Mindbio Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- WF60:GETTEX
- Asset type
- Stock
- Market cap
- $1.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Mindbio Therapeutics Corp. WF60:GETTEX stock context
This page tracks Mindbio Therapeutics Corp.'s WF60:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following WF60:GETTEX. WF60:GETTEX is the stock-level entry point for investors researching Mindbio Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Mindbio Therapeutics Corp.
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
May 11, 2026
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts us...
May 5, 2026
MindBio Files Patent Applications in 15 World Firsts
April 29, 2026
MindBio Appoints Market Maker Venture Liquidity Providers
April 14, 2026
MindBio Announces Closing of Private Placement
April 1, 2026
Research Mindbio Therapeutics Corp.
Mindbio Therapeutics Corp. investor report
Review AI stock analysis and investor report context for WF60:GETTEX.
Mindbio Therapeutics Corp. company profile
View the public company page for Mindbio Therapeutics Corp. on 6ix.
Mindbio Therapeutics Corp. news
Read company news and market updates connected to Mindbio Therapeutics Corp..
Mindbio Therapeutics Corp. investor events
Find investor webinars, events, and replay context for Mindbio Therapeutics Corp..
Alternate listings
MBIO:CSE
CA · CAD
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
MBQIF:OTC
US · USD
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
MBIO:NEO
CA · CAD
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
A41RJS:LS
DE · EUR
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
A41RJS:LSX
DE · EUR
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
WF60:FWB
DE · EUR
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
WF60:MUN
DE · EUR
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.
WF60:SWB
DE · EUR
Alternate listing for Mindbio Therapeutics Corp.; the primary context on this page is WF60:GETTEX.